scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-8993(01)02158-8 |
P698 | PubMed publication ID | 11292463 |
P2093 | author name string | F E Pontieri | |
F R Patacchioli | |||
A Scontrini | |||
F R Buttarelli | |||
P Monnazzi | |||
P2860 | cites work | Mesolimbic dopaminergic decline after cannabinoid withdrawal | Q34750833 |
Neurobiology of opiate abuse | Q36208827 | ||
A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse | Q39609704 | ||
Opioid and cannabinoid receptors | Q40628131 | ||
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal | Q40890918 | ||
Under siege: The brain on opiates | Q40986699 | ||
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain | Q42528679 | ||
Modulation of rat brain cannabinoid receptors after chronic morphine treatment | Q42546895 | ||
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain | Q44342706 | ||
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol | Q48141521 | ||
Functional correlates of heroin sensitization in the rat brain | Q48593949 | ||
Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbens | Q71495985 | ||
Metabolic mapping of the effects of WIN 55212-2 intravenous administration in the rat | Q73349562 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 178-180 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | Behavioral sensitization to WIN55212.2 in rats pretreated with heroin | |
P478 | volume | 898 |
Q37164808 | Advances in the field of cannabinoid--opioid cross-talk |
Q73578944 | Beta-phenylethylamines and the isoquinoline alkaloids |
Q30807024 | Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data |
Q45067725 | Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine |
Q40687653 | Chronic morphine treatment inhibits opioid receptor desensitization and internalization. |
Q34575484 | Drug addiction. |
Q38267170 | Electroacupuncture of 2 hz has a rewarding effect: evidence from a conditioned place preference study in rats |
Q35048784 | Endogenous opiates and behavior: 2001. |
Q46673452 | Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine |
Q52147495 | Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens. |
Q42519724 | Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum |
Q36309904 | Microinjection of WIN55,212-2 as A Cannabinoid Agonist into The Basolateral Amygdala Induces Sensitization to Morphine in Rats |
Q36259799 | Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence |
Q46513876 | Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity |
Q44371415 | Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. |
Q44437771 | WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation |
Search more.